Provided by Tiger Trade Technology Pte. Ltd.

Anavex Life Sciences

3.24
+0.11003.51%
Post-market: 3.21-0.0300-0.93%19:30 EDT
Volume:480.79K
Turnover:1.56M
Market Cap:300.26M
PE:-8.39
High:3.29
Open:3.17
Low:3.16
Close:3.13
52wk High:10.40
52wk Low:2.26
Shares:92.67M
Float Shares:91.12M
Volume Ratio:0.87
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3863
EPS(LYR):-0.5438
ROE:-30.78%
ROA:-19.50%
PB:2.47
PE(LYR):-5.96

Loading ...

Anavex delays filing quarterly Form 10-Q after missing deadline

Reuters
·
May 22

Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification

THOMSON REUTERS
·
May 22

U.S. Earnings Preview: Before Market Open May 19

Dow Jones
·
May 19

Top News Today: Stocks Mixed as Traders Await U.S.-Iran Updates

Dow Jones
·
May 19

Anavex options imply 6.3% move in share price post-earnings

TIPRANKS
·
May 19

Anavex Life Sciences Announces COO Departure Amid Restructuring

TIPRANKS
·
May 16

Anavex COO Felix Lauscher exits after interim CEO appointment

Reuters
·
May 16

Anavex Life Sciences files Form 3 for Interim CEO Terrie Kellmeyer

Reuters
·
May 15

Anavex delays filing quarterly report for March 31, 2026 quarter

Reuters
·
May 12

Anavex Life Sciences Corp expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
May 09

Anavex Life Sciences names Terrie Kellmeyer interim CEO, succeeding Missling

TIPRANKS
·
May 07

Anavex Life Sciences Names Interim CEO Amid Leadership Shift

TIPRANKS
·
May 06

Anavex names Terrie Kellmeyer interim CEO after Christopher Missling exit

Reuters
·
May 06

Press Release: Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer

Dow Jones
·
May 06

Anavex Life Sciences files Form 3 for director Axel Paeger

Reuters
·
May 02

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere

Reuters
·
Apr 14

Anavex plans pivotal studies of blarcamesine targeting autism-Alzheimer’s shared autophagy dysfunction

Reuters
·
Apr 14

Anavex Life Sciences to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 07

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 31

BRIEF-Anavex Life Sciences Provides Comprehensive Regulatory Update

Reuters
·
Mar 30